BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/RIPK3/Compounds

Compounds That Target RIPK3

receptor interacting serine/threonine kinase 3 · 36 compounds in BiohacksAI corpus

RIPK3 (receptor interacting serine/threonine kinase 3) is a biological target with 36 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into RIPK3 modulation for therapeutic and biohacking applications.

View RIPK3 target page →UniProt: Q9Y572 ↗
Most Studied Compounds for RIPK3
1
Vemurafenib
298+
studies
All 36 Compounds — Ranked by Evidence
1
Gefitinib
5.67
confidence
2
Ibrutinib
4.86
confidence
3
Cabozantinib
4.39
confidence
4
Foretinib
4.34
confidence
5
Ponatinib
4.26
confidence
6
Nilotinib
4.17
confidence
7
Quizartinib
3.99
confidence
8
Silmitasertib
3.78
confidence
9
Pazopanib
3.69
confidence
10
Regorafenib
3.56
confidence
11
Canertinib
3.53
confidence
12
Gilteritinib
3.40
confidence
13
Saracatinib
3.33
confidence
14
Fexagratinib
3.33
confidence
15
Dabrafenib
3.30
confidence
16
Gw305074x
3.14
confidence
17
Dacomitinib Anhydrous
3.14
confidence
18
Lenvatinib
3.04
confidence
19
Galunisertib
2.94
confidence
20
Tivozanib
2.64
confidence
21
Linsitinib
2.64
confidence
22
Motesanib
2.48
confidence
23
Poziotinib
2.48
confidence
24
Rebastinib
2.20
confidence
25
Golvatinib
2.20
confidence
26
Encorafenib
2.20
confidence
27
Cyc 116
2.08
confidence
28
Tg100 115
2.08
confidence
29
Osi 930
2.08
confidence
30
Cep 32496
1.95
confidence
31
Bafetinib
1.95
confidence
32
Sapitinib
1.95
confidence
33
Tucatinib
1.95
confidence
34
Rivoceranib
1.95
confidence
35
Varlitinib
1.79
confidence
36
Vemurafenib
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for RIPK3 (receptor interacting serine/threonine kinase 3). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: RIPK3 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.